Eidos Therapeutics
Improve and prolong the lives of patients suffering from transthyretin amyloidosis. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD396—593m (Dealroom.co estimates Apr 2018.)
Palo Alto California (HQ)
Authorizing premium user...